Name | Devonshire Acres |
---|---|
Location | 1330 Sidney Ave, Sterling, Colorado |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 84 |
Occupancy Rate | 66.9% |
Medicare ID (CCN) | 065150 |
Legal Business Name | Chancellor Health Care Of Colorado, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1194582189 |
Organization Name | DEVONSHIRE CARE CENTER, LLC |
Address | 1330 Sidney Ave, Sterling, CO 80751 |
Phone Number | 970-522-4888 |
News Archive
Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, today announce that Waypharm S.A.S (Waypharm) has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from CRT.
Kaiser Health News reports that most of these are people who sought coverage through the health law's Medicaid expansion. Meanwhile, the New York Times takes a look at how a state line can make all the difference in who gets Medicaid.
Statins appear to be safe for people with fatty liver disease who could benefit from their cholesterol-lowering capabilities, concludes a review paper published in the April 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
Researchers investigating eating disorders often study chemical and neurological functions in the brain to discover clues to overeating. Understanding non-homeostatic eating - or eating that is driven more by palatability, habit and food cues - and how it works in the brain may help neuroscientists determine how to control cravings, maintain healthier weights and promote healthier lifestyles. Scientists at the University of Missouri recently discovered the chemical circuits and mechanisms in the brain that separate food consumption from cravings. Knowing more about these mechanisms could help researchers develop drugs that reduce overeating.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, today announce that Waypharm S.A.S (Waypharm) has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from CRT.
Kaiser Health News reports that most of these are people who sought coverage through the health law's Medicaid expansion. Meanwhile, the New York Times takes a look at how a state line can make all the difference in who gets Medicaid.
Statins appear to be safe for people with fatty liver disease who could benefit from their cholesterol-lowering capabilities, concludes a review paper published in the April 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
Researchers investigating eating disorders often study chemical and neurological functions in the brain to discover clues to overeating. Understanding non-homeostatic eating - or eating that is driven more by palatability, habit and food cues - and how it works in the brain may help neuroscientists determine how to control cravings, maintain healthier weights and promote healthier lifestyles. Scientists at the University of Missouri recently discovered the chemical circuits and mechanisms in the brain that separate food consumption from cravings. Knowing more about these mechanisms could help researchers develop drugs that reduce overeating.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $61542 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 19.23 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.82 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.51 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.7 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.77 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.91 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.57 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 18.7 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 72.09 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 22.42 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.37 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.95 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.54 | 95.98 |
Percentage of short-stay residents who made improvements in function | 79.71 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 17.43 | 82.93 |
News Archive
Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, today announce that Waypharm S.A.S (Waypharm) has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from CRT.
Kaiser Health News reports that most of these are people who sought coverage through the health law's Medicaid expansion. Meanwhile, the New York Times takes a look at how a state line can make all the difference in who gets Medicaid.
Statins appear to be safe for people with fatty liver disease who could benefit from their cholesterol-lowering capabilities, concludes a review paper published in the April 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
Researchers investigating eating disorders often study chemical and neurological functions in the brain to discover clues to overeating. Understanding non-homeostatic eating - or eating that is driven more by palatability, habit and food cues - and how it works in the brain may help neuroscientists determine how to control cravings, maintain healthier weights and promote healthier lifestyles. Scientists at the University of Missouri recently discovered the chemical circuits and mechanisms in the brain that separate food consumption from cravings. Knowing more about these mechanisms could help researchers develop drugs that reduce overeating.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
› Verified 2 days ago